Page last updated: 2024-08-23

paroxetine and eicosapentaenoic acid

paroxetine has been researched along with eicosapentaenoic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chiu, CC; Huang, SY; Shen, WW; Su, KP1
Assies, J; Koeter, MW; Mocking, RJ; Ruhé, HG; Schene, AH; Vaz, FM; Verburg, HF; Westerink, AM1

Trials

1 trial(s) available for paroxetine and eicosapentaenoic acid

ArticleYear
Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Psychoneuroendocrinology, 2015, Volume: 59

    Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Depressive Disorder, Major; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Lipid Metabolism; Longitudinal Studies; Male; Paroxetine; Pituitary-Adrenal System; Saliva

2015

Other Studies

2 other study(ies) available for paroxetine and eicosapentaenoic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Omega-3 fatty acids for depression in pregnancy.
    The American journal of psychiatry, 2003, Volume: 160, Issue:2

    Topics: Adult; Depressive Disorder; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003